A study to investigate the pharmacokinetics of a single inhaled dose (400mcg) of GW685698X [fluticasone furoate] and its effect on serum cortisol in patients with impaired liver function and matched control subjects.
Phase of Trial: Phase I
Latest Information Update: 08 Nov 2017
At a glance
- Drugs Fluticasone furoate (Primary)
- Indications Asthma; Perennial allergic rhinitis; Seasonal allergic rhinitis; Sinusitis
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 06 Feb 2007 New trial record.